Published in Nature on February 16, 1995
Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem (1996) 5.52
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res (2008) 3.63
Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol (1997) 1.80
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biol Ther (2009) 1.78
TAM receptor signaling and autoimmune disease. Curr Opin Immunol (2010) 1.63
A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol (1999) 1.62
Structural basis for Gas6-Axl signalling. EMBO J (2005) 1.56
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest (2005) 1.55
Minding the gaps to promote thrombus growth and stability. J Clin Invest (2005) 1.53
The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes. Proc Natl Acad Sci U S A (2003) 1.51
Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol (1996) 1.50
MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med (2008) 1.48
Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin. EMBO J (2000) 1.46
Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest (1996) 1.43
TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci (2010) 1.39
Axl is essential for VEGF-A-dependent activation of PI3K/Akt. EMBO J (2012) 1.38
Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol (1999) 1.33
Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J (1997) 1.30
Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J Neuroimmune Pharmacol (2007) 1.28
Axl-dependent signalling: a clinical update. Clin Sci (Lond) (2012) 1.28
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22
Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J (1996) 1.21
Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells. Mol Cell Biol (2001) 1.21
Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol (1999) 1.19
The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. Oncogene (2012) 1.17
Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase. Mol Cell Biol (2002) 1.17
Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest (2008) 1.16
Targeting Axl with an high-affinity inhibitory aptamer. Mol Ther (2012) 1.14
Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase. Mol Cell Biol (1995) 1.13
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Elife (2014) 1.11
The platelet-derived growth factor alpha-receptor is encoded by a growth-arrest-specific (gas) gene. Proc Natl Acad Sci U S A (1996) 1.11
Retracted Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell Biol (2005) 1.10
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood (2008) 1.07
Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons. Neuroscience (2007) 1.05
Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology (2010) 1.05
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood (2010) 1.04
Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am J Pathol (2009) 1.03
Vitamin K and the nervous system: an overview of its actions. Adv Nutr (2012) 1.03
Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6). Proc Natl Acad Sci U S A (2000) 1.01
Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy. Clin Cancer Res (2016) 1.00
Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer (2008) 1.00
Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mol Cancer Res (2012) 0.99
Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr (2012) 0.97
A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody. Biochem J (2005) 0.97
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis. Nat Chem Biol (2014) 0.96
Vitamin K-dependent carboxylation of the carboxylase. Proc Natl Acad Sci U S A (1998) 0.96
Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients. Ann Surg Oncol (2012) 0.95
Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain (2010) 0.95
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. J Clin Invest (2013) 0.94
TAM receptors in leukemia: expression, signaling, and therapeutic implications. Crit Rev Oncog (2011) 0.94
Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2008) 0.93
Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One (2009) 0.92
Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteins. Proc Natl Acad Sci U S A (1997) 0.92
Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Mol Cell Biol (1999) 0.92
TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system. Brain Res (2013) 0.91
Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc Natl Acad Sci U S A (2001) 0.91
Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. PLoS One (2012) 0.88
Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model. Mol Reprod Dev (2009) 0.88
In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation. J Neurochem (2008) 0.88
Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy. Neoplasia (2014) 0.87
Effects of nutrient deprivation and differentiation on the expression of growth-arrest genes (gas and gadd) in F9 embryonal carcinoma cells. Biochem J (1998) 0.87
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Res (2015) 0.86
Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB. Hypertension (2010) 0.85
Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis. J Neurosci (2014) 0.83
Critical signal transduction pathways in CLL. Adv Exp Med Biol (2013) 0.81
Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins. J Virol (1996) 0.81
Prediction of solution structures of the Ca2+-bound gamma-carboxyglutamic acid domains of protein S and homolog growth arrest specific protein 6: use of the particle mesh Ewald method. Biophys J (1997) 0.81
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis. Mediators Inflamm (2013) 0.80
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest (2016) 0.79
A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis. J Clin Invest (1997) 0.79
Liver-specific γ-glutamyl carboxylase-deficient mice display bleeding diathesis and short life span. PLoS One (2014) 0.78
The stimulation of mitogenic signaling pathways by N-POMC peptides. Mol Cell Endocrinol (2008) 0.78
Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol (2014) 0.78
The health benefits of vitamin K. Open Heart (2015) 0.77
Giving AXL the axe: targeting AXL in human malignancy. Br J Cancer (2017) 0.77
Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease. Blood (2010) 0.77
Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction. Ups J Med Sci (2010) 0.77
A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6. Cancer Sci (2016) 0.77
Protective Effects of Growth Arrest-Specific Protein 6 (Gas6) on Sepsis-Induced Acute Kidney Injury. Inflammation (2016) 0.77
Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. PLoS One (2016) 0.76
VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases? Nutrients (2015) 0.76
TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. Oncotarget (2016) 0.75
TAM receptor tyrosine kinase function and the immunopathology of liver disease. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Topical vitamin K1 promotes repair of full thickness wound in rat. Indian J Pharmacol (2014) 0.75
AXL receptor tyrosine kinase as a therapeutic target in NSCLC. Lung Cancer (Auckl) (2015) 0.75
Targeting the TAM Receptors in Leukemia. Cancers (Basel) (2016) 0.75
The Gas6/TAM System and Multiple Sclerosis. Int J Mol Sci (2016) 0.75
Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene. Asian-Australas J Anim Sci (2017) 0.75
GAS6 expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Mol Oncol (2017) 0.75
The Axl Kinase Domain in Complex with a Macrocyclic Inhibitor Offers First Structural Insights into an Active TAM Receptor Kinase. J Biol Chem (2017) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A (1993) 5.11
The virD operon of Agrobacterium tumefaciens encodes a site-specific endonuclease. Cell (1986) 4.20
Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol (2001) 3.80
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun (1984) 3.63
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron (1995) 3.08
Synthesis of nitric oxide in CNS glial cells. Trends Neurosci (1993) 2.81
Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell (1992) 2.77
Dentistry and anaesthesia. Br Dent J (1993) 2.56
Voluntary regionalization and associated trends in perinatal care: the Nova Scotia Reproductive Care Program. Am J Obstet Gynecol (1983) 2.45
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun (1984) 2.42
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
Inguinal hernia: a common problem of premature infants weighing 1,000 grams or less at birth. Pediatrics (1975) 2.34
Overt and subclinical hypothyroidism complicating pregnancy. Thyroid (2002) 2.30
Relaxation of a transfer RNA specificity by removal of modified nucleotides. Nature (1990) 2.20
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems. J Clin Microbiol (1994) 2.17
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past. Trop Med Int Health (2008) 2.00
Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol (1998) 1.99
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol (1997) 1.97
Conformation in solution of yeast tRNA(Asp) transcripts deprived of modified nucleotides. Biochimie (1990) 1.97
Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain (2006) 1.95
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol (2001) 1.93
Medical Investigation of Retinal Vascular Occlusion. Br Med J (1964) 1.93
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry (1998) 1.84
A randomized controlled trial of a computer-based physician workstation in an outpatient setting: implementation barriers to outcome evaluation. J Am Med Inform Assoc (1997) 1.83
Occupation and cancer in Britain. Br J Cancer (2010) 1.83
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med (2000) 1.72
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health (1999) 1.67
Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol (1996) 1.66
Correlations between molecular subtyping and serotyping of Listeria monocytogenes. J Clin Microbiol (2001) 1.66
Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Paediatr Suppl (2002) 1.63
Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med (2001) 1.63
Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories. J Infect Dis (1980) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58
Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J (1997) 1.57
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet (1995) 1.53
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J Antimicrob Chemother (2001) 1.53
The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem (1995) 1.52
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J (2001) 1.50
Effect of storage temperature on sperm cryopreservation. Fertil Steril (1998) 1.49
Sequence of human villin: a large duplicated domain homologous with other actin-severing proteins and a unique small carboxy-terminal domain related to villin specificity. J Cell Biol (1988) 1.49
Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease. Am J Cardiol (1994) 1.49
Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol (2005) 1.48
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48
Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J Clin Microbiol (1998) 1.47
Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg (1996) 1.47
A case of neuroleptic malignant syndrome and serotonin disturbance. J Clin Psychopharmacol (1997) 1.46
Reduced amounts and abnormal forms of phospholipase C zeta (PLCzeta) in spermatozoa from infertile men. Hum Reprod (2009) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Behavior of resting Aedes aegypti (Culicidae: Diptera) and its relation to ultra-low volume adulticide efficacy in Panama City, Panama. J Med Entomol (2000) 1.41
Current status of radiosurgery for arteriovenous malformations. Can J Neurol Sci (1991) 1.41
Kidney graft survival in patients with hepatitis C: a single center experience. Clin Transplant (2008) 1.41
Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer (1995) 1.41
Fibroelastoma: case report and review of the literature. Heart (1998) 1.40
Licensure requirements and mobility of Canadian dentists. J Can Dent Assoc (1999) 1.40
Effect of the social environment on alcohol involvement and subjective well-being prior to alcoholism treatment. J Stud Alcohol (1993) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. Nucl Med Biol (2000) 1.39
The hospice movement matures. Med J Aust (1996) 1.38
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature (1994) 1.37
An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl Radiat Isot (2001) 1.36
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry (1997) 1.35
Fluorescent tagging of herpes simplex virus tegument protein VP13/14 in virus infection. J Virol (2001) 1.35
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail (2001) 1.35
A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture. EMBO J (1986) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci U S A (1999) 1.34
Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol (1997) 1.33
Use of the BacT/Alert blood culture system for culture of sterile body fluids other than blood. J Clin Microbiol (1998) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
An infertile male with balanced Y;19 translocation. Review of Y;autosome translocations. Ann Genet (1979) 1.31
Ethyl chloride and venepuncture pain: a comparison with intradermal lidocaine. Can J Anaesth (1990) 1.30
Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14. J Virol (2001) 1.30
Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology (2000) 1.30
Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev (2003) 1.30
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol (2009) 1.29
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther (1999) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci (1995) 1.27
Abnormal white matter signal on MR imaging is related to abnormal tissue microstructure. AJNR Am J Neuroradiol (2009) 1.26
Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev (1999) 1.26
Evaluation of VP22 spread in tissue culture. J Virol (2000) 1.25
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res (1995) 1.25
Replication control in promiscuous plasmid RK2: kil and kor functions affect expression of the essential replication gene trfA. J Bacteriol (1985) 1.24
The inverse relationship between cost and survival in the critically ill cancer patient. Crit Care Med (1979) 1.24
The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg (1996) 1.23
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B. Hepatology (2000) 1.23